The molecular mechanism involved in altered regulation of the rate-limiting enzyme in hepatic gluconeogenesis, phosphoenolpyruvate carboxykinase (PEPCK), during endotoxemia is not completely understood. We examined, therefore, the effect of a nonlethal dose of Escherichia coli endotoxin on PEPCK gene expression in fasted rats. 5 h after endotoxin treatment, the PEPCK transcription rate and the amount of mRNAPEI'K were significantly decreased at a time when the insulin/glucagon (I/ G) molar ratio and plasma corticosterone levels were significantly increased. Similar results were observed in a time course study, in which altered cAMP induction of PEPCK gene expression paralleled changes in the I/G molar ratio. In diabetic rats treated with endotoxin, PEPCK gene expression was decreased in the absence, however, of an increased I/G molar ratio. This finding indicates that other factors, such as inflammatory mediators or cytokines, alter PEPCK gene transcription during endotoxemia. IL-6, a putative mediator of endotoxin action in the liver, had no effect on PEPCK gene expression in fasted rats, but did decrease cAMP induction of PEPCK gene expression. These results indicate that, during endotoxemia, regulation of PEPCK gene expression is influenced by inflammatory mediators in addition to the classical endocrine hormones. IL-6, however, does not appear to be involved directly in the altered regulation ofthe PEPCK gene during endotoxemia. (J. Clin. Invest. 1991. 88:811-816.)
Introduction
Acute bacterial infections and a serious sequela, septic shock, remain significant health problems despite appropriate antimicrobial and supportive therapies. Septic or endotoxic shock is a complex syndrome characterized by hypotension, poor organ perfusion, and severe systemic metabolic derangements, particularly hypoglycemia. Hypoglycemia results from increased peripheral utilization ofglucose, rapid depletion ofliver glycogen, and depressed hepatic gluconeogenesis (1) . It is well established gluconeogenic enzymes, particularly phosphoenolpyruvate carboxykinase (PEPCK),' the rate-limiting enzyme in gluconeogenesis (2) (3) (4) (5) . As expected, decreased hepatic PEPCK enzyme activity in endotoxin-poisoned animals is accompanied by decreased gluconeogenesis (2, 6) .
PEPCK plays a pivotal role in intermediary carbohydrate metabolism and the complex multihormonal control of the PEPCK gene reflects the importance of this enzyme in hepatic glucose production (7) . Glucagon, via cAMP, and glucocorticoids (to a lesser extent) positively regulate PEPCK primarily by increasing the transcription rate of the gene (8, 9) and by stabilizing mRNAPElCK (mRNA coding for PEPCK) (10, 1 1). Conversely, insulin negatively regulates PEPCK by decreasing the transcription rate of the gene (12) , an effect that is dominant over the inductive effect of cAMP and glucocorticoids in cell culture when all three hormones are present (13) . Because all three hormones are present in vivo, the insulin/glucagon (I/G) molar ratio serves as an index of the metabolic status or gluconeogenic potential of the animal (14, 15) . Endotoxin treatment of rats and mice results in increased plasma levels of glucagon, glucocorticoids, and insulin (16, 17) , resulting in a very complex hormonal milieu. The hormonal status of endotoxin-treated animals is further complicated by the appearance in the circulation of inflammatory cytokines such as IL-1, TNF, and IL-6 (18) . Human recombinant IL-l and TNF, as well as purified murine IL-6, have been shown to decrease PEPCK enzyme activity in Reuber hepatoma cells (19, 20) , but few studies have been conducted to examine the effect of cytokines on the regulation ofPEPCK gene expression in vivo (21) .
The purpose ofthis study, therefore, was to determine ifthe endotoxin-mediated decrease in PEPCK enzyme activity reported previously is due to decreased transcription of the PEPCK gene and ifthe putative decrease in PEPCK gene transcription is mediated solely by insulin. Our eventual goal is to determine how inflammatory cytokines interact with endocrine hormones (glucagon, glucocorticoids, and insulin) to regulate the hepatic PEPCK gene and gluconeogenesis during acute infection and inflammation.
Methods
Animals. Male, Sprague-Dawley rats (100-125 g) were purchased from Sasco (Omaha, NE). Animals were housed and cared for under the National Institutes of Health (NIH) guidelines for the care and use of laboratory animals. In some experiments, rats were treated with streptozotocin (Sigma Chemical Co., St. Louis, MO) to induce diabetes. After an overnight fast, rats were treated with 90 mg/kg ofstreptozotocin. 5 h later, food was returned to the cages and the animals were tested 7 to 10 d later for plasma glucose levels. Animals were considered diabetic and included in the study if their plasma glucose values were > 500 mg/dl. All experimental protocols were approved by the Institutional Animal Care and Utilization Committee (IACUC) at the University of Oklahoma Health Sciences Center.
Endotoxin andIL-6. Endotoxin was prepared from Escherichia coli serotype 011 l:B4 by the Westphal method (22) and was essentially protein and RNA free. The LD.o of this preparation, in Sprague-Dawley rats, was 35.5 mg/kg as determined by the Reed-Muench method (23) . No deaths were observed during the course of the experiments described below, using a dose of 10 mg/kg. Recombinant human IL-6 was purchased from Boehringer-Mannheim Biochemicals (Indianapolis, IN). The specific activity of IL-6 was greater than 2 X 10 U/mg, as determined by stimulation of 7TDl mouse-mouse hybridoma cells (24) .
Nuclear run-on assay. The transcription elongation assay was carried out according to the procedure of Sasaki et al. (13) , which was modified from the method of McKnight and Palmiter (25) . After homogenization of liver tissue, nuclei were isolated through a series of centrifugations in sucrose buffers. (29) from Pierce Chemical Co. (Rockford, IL). Plasma glucagon and insulin levels were measured using radioimmunoassay kits from Ventrex Laboratories (Cambridge, MA) and plasma corticosterone levels were measured using a radioimmunoassay kit from ICN Bio Medicals, Inc. (Costa Mesa, CA). Plasma glucose levels were measured using a colorimetric glucose oxidase assay kit from Sigma Chemical Co.
Induction ofPEPCK gene transcription in vivo. There are primarily two ways to increase the transcription rate of the PEPCK gene in animals. The simplest method is by fasting overnight, which lowers the insulin/glucagon (I/G) molar ratio and results in an approximately twofold induction in the rate of transcription. Another method is by dietary manipulation which involves submitting the animal to a fasting-refeeding cycle followed by injection with cAMP (30) . This experimental protocol, described originally by lynedjian et al. (30) , was used to manipulate the hormonal response in rats so that changes in the PEPCK transcription rate could be examined after endotoxin treatment. Briefly, animals were fasted overnight, refed with glucose (0.5 g) by gavage, and 2 h later dibutyryl cAMP (30 mg/kg) and theophylline (30 mg/kg) were administered intraperitoneally. Animals received dibutyryl-cAMP and theophylline (referred to hence as cAMP) every 90 min thereafter. Glucose feeding stimulates insulin release, which deinduces PEPCK gene expression (31, 32) . Any increase in the PEPCK transcription rate can, therefore, be observed after administration of inducer (cAMP) (30, (32) (33) . The advantage of dietary manipulation over fasting is that the induction of PEPCK gene transcription is rapid and large. We have used both methods in the results described below.
Statistics. Statistical analysis of the data was performed by using Student's t test (34) .
Results
Effect ofendotoxin on PEPCK gene expression. Previous work has shown that endotoxin treatment decreases PEPCK enzyme activity in mice 4 to 6 h after challenge (35, 36) . The effect of endotoxin on transcriptional regulation of the PEPCK gene, however, has not been examined directly. Changes in PEPCK gene expression and circulating levels ofinsulin, glucagon, and corticosterone were assessed, therefore, in fasted rats 5 h after endotoxin treatment (10 mg/kg) ( Table I) . Endotoxin treatment significantly decreased the PEPCK transcription rate and amount of mRNAPEPc to approximately one-third of control.
No change in mRNA1 was observed (data not shown). As expected, the hormonal status of endotoxin-treated animals was significantly altered, as indicated by a ninefold increase in the I/G molar ratio and a fourfold increase in plasma corticosterone levels, compared with saline-treated controls. In rats given endotoxin, insulin values rose 18-fold (control = 2.4±0.7 ,uU/ ml vs. endotoxin = 44.0±3. 4 ,U/ml) and glucagon values doubled (control = 1,352±97 pg/ml vs. endotoxin = 2,734±251 pg/ml). Similar changes in the PEPCK transcription rate were observed in rats given free access to food and treated with saline or endotoxin (control = 2,437 ppm vs. endotoxin = 1,355 ppm, n = 2).
Altered cAMP induction of PEPCK gene expression after endotoxin treatment. To examine further the mechanism of altered PEPCK gene expression in endotoxic animals, the effect ofendotoxin treatment on cAMP induction ofPEPCK was tested. Endotoxin was injected 2 h before cAMP treatment because it has been demonstrated that serum levels of many inflammatory cytokines appear and/or peak 2 h after endo- toxin administration (18) . The results are presented as a percentage ofinduced control due to variation from experiment to experiment. As can be seen in Fig. 1 , a dynamic response to endotoxin was observed over the course of 8 h. By 3.5 h after endotoxin treatment, no significant change in the PEPCK transcription rate or mRNAPE' level was observed in endotoxin plus cAMP-treated animals compared with induced controls. Significant inhibition of the PEPCK transcription rate and mRNA"E'P level by endotoxin treatment, however, was observed at 5 h (control = 2,833±794 ppm vs. endotoxin = 644±24 ppm, P < 0.05). At 8 h, PEPCK gene expression was not different from the induced controls. PEPCK enzyme activity was also significantly decreased in the endotoxin-treated group, compared with the induced controls at the 5-h time point. PEPCK enzyme activity was increased over deinduced controls (animals receiving glucose only) by 262 U/mg compared with 134 U/mg in endotoxic animals (51% of induced controls, P < 0.05). 6 h after cAMP treatment (8 h after endotoxin), PEPCK enzyme activity was not significantly different from induced controls.
The plasma profiles ofinsulin, glucagon, and the I/G molar ratio, in control and endotoxic animals subjected to fasting-refeeding and cAMP injection, are illustrated in Fig. 2 . Endotoxin treatment significantly increased insulin levels after 3.5 and 5 h, however, by 8 h, the insulin values in control and endotoxic rats were similar. In contrast to the insulin response, glucagon levels were increased by 2 h after endotoxin treatment and remained elevated by 8 h. At 3.5 and 5 h, the I/G molar ratio was increased in endotoxic animals (although not statistically different from induced controls at 5 h), yet by 8 h the I/G molar ratio was similar to the induced controls. The increased insulin levels and the I/G molar ratio correlated well with decreased PEPCK gene expression in endotoxin-treated animals and suggested a role for insulin in downregulation of PEPCK gene expression during endotoxemia.
PEPCK gene expression in diabetic rats after endotoxin treatment. In order to examine further the role ofinsulin in the downregulation of PEPCK gene expression during endotoxe- (8), we tested whether IL-6, via increased corticosterone levels, could enhance the cAMP induction of PEPCK gene expression, using the experimental protocol described in the legend to Fig. 1 . Animals were treated with IL-6 (10,000 U) simultaneously with glucose and killed 5 h later (after 3 h of cAMP treatment). Interestingly, IL-6 treatment resulted in a significant decrease in the PEPCK transcription rate and mRNAPE1 levels, compared with induced controls (Table III) . No significant change in PEPCK enzyme activity was observed, however, in the IL-6-treated animals, compared with induced controls (induced controls = 262±13 U/mg vs. IL-6 = 214±21 U/mg). In addition, no significant change occurred in the I/G molar ratio, compared with the induced controls.
Discussion
The molecular mechanisms involved in decreased gluconeogenesis after endotoxin treatment have not been fully elucidated. The data presented here demonstrate that the previously observed decrease in PEPCK enzyme activity after endotoxin * Rats were treated as described in the legend to Fig. 1 , except that IL-6 (10,000 U) was injected instead of endotoxin and the animals were killed at the 5-h time point. * Mean value±SEM, n = 4. It has been well documented that the effect of endotoxin to inhibit hepatic gluconeogenesis and PEPCK is not a direct effect of endotoxin on the liver (1, 2, 6, 37) . IL-1, TNF, and IL-6 have been implicated as mediators of the endotoxin effect on PEPCK because they decrease enzyme activity and mRNAPE' in vitro in Reuber H-4-II-E rat hepatoma cells (19, 20, 38) . Multiple cytokines appear in the circulation after endotoxin treatment and may elicit the production of additional cytokines, resulting in a cascade of inflammatory mediators (18) . We chose to examine IL-6 as a putative mediator of endotoxin action on PEPCK gene expression because IL-6 is the dominant cytokine involved in induction of the hepatic acute phase proteins (39) (40) (41) and because endotoxin, TNF, and IL-1 elicit IL-6 production (42, 43). IL-6 acts via a specific membrane receptor (44) and after binding there is increased transcription of hepatic acute phase genes, such as a2-macroglobulin, haptoglobin, cysteine proteinase inhibitor, and a1-acid glycoprotein. Concomitantly, synthesis of several acute phase proteins, such as albumin, is decreased after treatment with IL-6 (39-41). The dose of IL-6 (10,000 U/100 g rat) used in these studies was chosen based on a previous study by Marinkovic et al. (45) who reported that 40,000 U IL-6 per 400 g rat were necessary to elicit the same acute phase response quantitatively as an acute inflammatory agent, turpentine.
The results we obtained with IL-6 treatment are interesting, but somewhat perplexing. IL-6 treatment, after 5 h, had no effect on (11), it is not known ifthe observed increase in corticosterone levels after IL-6 treatment contributed to increased mRNAPEICR stabilization. The observation that no significant change in PEPCK enzyme activity occurred in the IL-6-treated animals lends support to this idea. One explanation for the IL-6 inhibition of cAMP-mediated induction of PEPCK gene expression might be that IL-6 acts as an insulin-like factor (46) or that the cytokine prolongs the action of insulin when it is administered at the same time as glucose. Other investigators have reported that IL-6 enhances glucose-stimulated production of insulin from isolated pancreatic ,8-cells (47) , however, we observed no change in insulin levels after IL-6 treatment.
Although an IL-6 response element has not been mapped on the promoter region ofthe PEPCK gene, a core hexanucleotide CTGGGA sequence found in the promoter region of IL-6 responsive genes, is found in the 5-flanking region ofthe PEPCK gene described as the glucocorticoid response unit (GRU) (48) . A portion ofthe GRU also overlaps with the recently described insulin response element (IRE) (49) . This raises the possibility, although purely speculative, that putative nuclear elements or factors mediating the IL-6 effect on the PEPCK gene, under certain conditions, interact at the GRU, IRE, or the cAMP response element.
Although insulin decreases PEPCK synthesis after the appropriate dietary stimulus in normal animals, it is clear from our results that other factors in addition to insulin contribute to the negative regulation of the PEPCK gene during endotoxemia. We observed in this study that endotoxin elicited a transient change in PEPCK gene expression, however, the change occurred at a critical time in the development of progressive hypoglycemia (2) . When larger doses of endotoxin (LDsO) are administered, PEPCK enzyme activity is significantly decreased at a time coincident with developing hypoglycemia (4-6 h) and remains depressed throughout the course ofthe experiment (2) . Although decreased PEPCK enzyme activity is not solely responsible for the observed hypoglycemia in septic animals, it is an important factor in the failure of the gluconeogenic pathway to provide sufficient glucose to satisfy the increased energy demands ofthe injured host. Further studies are required to identify putative inflammatory mediators involved and to elucidate how they interact with insulin in negatively regulating PEPCK gene expression during acute infection and inflammation.
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